5[11]Mugitani T, Taniguchi H, Takada A, et al. TNP-470 inhibits collater alization to complements the anti-tumor effect to hepatic artery ligation.Br J Cancer , 1998,77(4) :638 ～ 642.
3Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significent and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst, 1992, 84:1875-1887.
4Augustin HG. Angiogenic tumor therapy: will it work? Trends Pharmacol Sci, 1998, 19:216-222.
5Gospodarowicz D, Ferrara N, Schweigerer L, et al. Structural characterization and biological functions of fibroblast growth factor.Endocr Rev,1987, 8:95-114.
6Van der Zee R, Murohara T, Lao Z, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation, 1997,95 : 1030-1037.
7Toi M, Hoshina S, Takayanagi T, et al. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res, 1994, 85:1045-1049.
8Bosari S, Lee AK, DeLellis RA, et al. Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol, 1992,23:755-761.
9Van Hoef ME, Knox WF, Dhesi SS, et al. Assessment of tumour vascularity as a prognostic fator in lymph node negative invasive breast cancer. Eur J Cancer, 1993,29A:1141-1145.
10Medri L, Nanni O, Volpi A, et al. Tumor microvessel density and prognosis in node-negative breast cancer. Int J Cancer, 2000,89:74-80.
9Stephanou A, Mcdougall SR,Anderson ARA, et al. Mathematical modeling of flow on 2D and 3D vascular networks: Applications to anti - angiogenic and chemotherapeutic drug strategies [ J ]. Mathematical and Computer Modeling, 2005,4:1137 - 1156.
10McDougall SR, Anderson ARA, Chaplain MAJ,et al. Mathematical modeling of flow through vascular network : Implications for tumor - induced angiogenesis and chemotherapy strategies[ J ]. Bulletin of Mathematical Biology, 2002,64 : 673 - 702.
